Early diagnosis of lung cancer: which is the optimal choice?
- PMID: 33591942
- PMCID: PMC7950268
- DOI: 10.18632/aging.202504
Early diagnosis of lung cancer: which is the optimal choice?
Abstract
The prognosis of lung cancer patients with different clinical stages is significantly different. The 5-year survival of stage IA groups can exceed 90%, while patients with stage IV can be less than 10%. Therefore, early diagnosis is extremely important for lung cancer patients. This research focused on various diagnosis methods of early lung cancer, including imaging screening, bronchoscopy, and emerging potential liquid biopsies, as well as volatile organic compounds, autoantibodies, aiming to improve the early diagnosis rate and explore feasible and effective early diagnosis strategies.
Keywords: LDCT; bronchoscopy; diagnosis; liquid biopsy; lung cancer.
Conflict of interest statement
Figures
Similar articles
-
Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy.Respir Care Clin N Am. 2003 Mar;9(1):51-76. doi: 10.1016/s1078-5337(02)00083-7. Respir Care Clin N Am. 2003. PMID: 12820712 Review.
-
A volatile biomarker in breath predicts lung cancer and pulmonary nodules.J Breath Res. 2019 Jun 19;13(3):036013. doi: 10.1088/1752-7163/ab21aa. J Breath Res. 2019. PMID: 31085817
-
Progress in the development of volatile exhaled breath signatures of lung cancer.Ann Am Thorac Soc. 2015 May;12(5):752-7. doi: 10.1513/AnnalsATS.201411-540OC. Ann Am Thorac Soc. 2015. PMID: 25965541 Free PMC article.
-
[Progress of Liquid Biopsy in Early Diagnosis of Lung Cancer].Zhongguo Fei Ai Za Zhi. 2018 Aug 20;21(8):620-627. doi: 10.3779/j.issn.1009-3419.2018.08.08. Zhongguo Fei Ai Za Zhi. 2018. PMID: 30172270 Free PMC article. Review. Chinese.
-
[The Methods and Clinical Significance of Early Diagnosis of Lung Cancer].Sichuan Da Xue Xue Bao Yi Xue Ban. 2017 May;48(3):331-335. Sichuan Da Xue Xue Bao Yi Xue Ban. 2017. PMID: 28616901 Review. Chinese.
Cited by
-
PPARγ Modulators in Lung Cancer: Molecular Mechanisms, Clinical Prospects, and Challenges.Biomolecules. 2024 Feb 4;14(2):190. doi: 10.3390/biom14020190. Biomolecules. 2024. PMID: 38397426 Free PMC article. Review.
-
A retrospective diagnostic test study on circulating tumor cells and artificial intelligence imaging in patients with lung adenocarcinoma.Ann Transl Med. 2022 Dec;10(24):1339. doi: 10.21037/atm-22-5668. Ann Transl Med. 2022. PMID: 36660706 Free PMC article.
-
Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules.Heliyon. 2024 May 3;10(9):e30576. doi: 10.1016/j.heliyon.2024.e30576. eCollection 2024 May 15. Heliyon. 2024. PMID: 38765082 Free PMC article.
-
Lung Cancer Biomarker Database (LCBD): a comprehensive and curated repository of lung cancer biomarkers.BMC Cancer. 2025 Mar 15;25(1):478. doi: 10.1186/s12885-025-13883-w. BMC Cancer. 2025. PMID: 40089661 Free PMC article.
-
LungHist700: A dataset of histological images for deep learning in pulmonary pathology.Sci Data. 2024 Oct 5;11(1):1088. doi: 10.1038/s41597-024-03944-3. Sci Data. 2024. PMID: 39368979 Free PMC article.
References
-
- Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo E Silva G, Chen WQ, et al., and CONCORD Working Group. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 Countries. Lancet. 2018; 391:1023–75. 10.1016/S0140-6736(17)33326-3 - DOI - PMC - PubMed
-
- Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, et al., and National Lung Screening Trial Research Team. The National lung screening trial: overview and study design. Radiology. 2011; 258:243–53. 10.1148/radiol.10091808 - DOI - PMC - PubMed
-
- Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V, and International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016; 11:39–51. 10.1016/j.jtho.2015.09.009 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical